Newsfeeds Archive - Spark Newswire

3 minute read

Cathie Wood’s Ark Innovation ETF Sees Sharp Decline Among Top Holdings — Here Are 10-Largest Losers Within ARKF

May 28, 7:29 AM

Cathie Wood's flagship ARK Innovation ETF has been navigating through significant losses, showcasing the challenges faced by some of its major holdings.

ARKK

2 minute read

How Is The Market Feeling About Ginkgo Bioworks Holdings?

By Benzinga Insights

May 23, 11:00 AM

Ginkgo Bioworks Holdings’s (NYSE:DNA) short percent of float has risen 7.94% since its last report. The company recently…

DNA

2 minute read

Investment Advisor Says ‘Throwing Random Darts At Tickers’ Would Beat ARKK As Cathie Wood’s Flagship Fund Lags Far Behind Soaring Market: ‘How Do They Do It?!’

By Shanthi Rexaline

May 20, 6:51 AM

Ram Ahluwalia of Lumida Wealth pointed to Ark's flagship ETF trading over 70% below its all-time high amid the S&P 500's recent record highs.

ARKF

2 minute read

TeraWulf Posts Weak Results, Joins StoneCo And Other Big Stocks Moving Lower In Tuesday’s Pre-Market Session

By Avi Kapoor

May 14, 5:24 AM

U.S. stock futures were slightly higher this morning, with the Dow futures gaining around 20 points on Tuesday.…

BUR

5 minute read

Why Diodes Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Friday’s Mid-Day Session

By Avi Kapoor

May 10, 12:44 PM

Shares of Diodes Incorporated (NASDAQ:DIOD) fell sharply during Friday’s session after the company reported worse-than-expected quarterly financial results.…

ACIC

2 minute read

Akamai Technologies Issues Weak Outlook, Joins Applied Optoelectronics, JFrog And Other Big Stocks Moving Lower In Friday’s Pre-Market Session

By Avi Kapoor

May 10, 5:45 AM

U.S. stock futures were higher this morning, with the Dow futures gaining around 100 points on Friday. Shares…

AAOI

2 minute read

Ginkgo Bioworks Stock Falls On Disappointing Q1 Sales: ‘This Trend Needs To Change’

By Erica Kollmann

May 9, 4:49 PM

Ginkgo Bioworks reported quarterly sales of $38 million which missed the analyst consensus estimate of $46.044 million by 17.47% and is a 52.91% decrease in sales year-over-year. The company said the decrease in sales was primarily driven by the expected ramp down of K-12 testing in Ginkgo's Biosecurity segment.

DNA

4 minute read